INBS (Intelligent Bio Solutions) Stock Based Compensation: $0.11 Mil (TTM As of Mar. 2026)


INBS Intelligent Bio Solutions Inc INBS
49 GF Score
Price $2.25
GF Value $2.61
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Intelligent Bio Solutions Stock Based Compensation?

Intelligent Bio Solutions INBS +4.17% 49 Stock Based Compensation is $0.11 Mil as of Mar. 2026. GuruFocus rates INBS with a GF Score™ of 49/100 and a GF Value™ of $2.61 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Intelligent Bio Solutions's Stock Based Compensation for the three months ended in Mar. 2026 was $0.02 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11 Mil.

Intelligent Bio Solutions Stock Based Compensation Related Terms

Intelligent Bio Solutions Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Intelligent Bio Solutions's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intelligent Bio Solutions Stock Based Compensation Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.26 0.23 0.24

Intelligent Bio Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.06 0.02
INBS
49GF Score
Intelligent Bio Solutions Inc INBS
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intelligent Bio Solutions Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11 Mil.

What does a Stock Based Compensation of $0.11 Mil mean?
Intelligent Bio Solutions (INBS) has a Stock Based Compensation of $0.11 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Intelligent Bio Solutions and its competitors.
Is Intelligent Bio Solutions' Stock Based Compensation too high?
Intelligent Bio Solutions' current Stock Based Compensation is $0.11 Mil. Overall, Intelligent Bio Solutions has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Stock Based Compensation compare to ITOC and WOK?
Intelligent Bio Solutions' Stock Based Compensation of $0.11 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Intelligent Bio Solutions and its competitors. Intelligent Bio Solutions's current Stock Based Compensation is $0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.61, compared to a current price of $2.25 — trading 13.8% below its estimated fair value. The current Stock Based Compensation is $0.11 Mil. Intelligent Bio Solutions' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Stock Based Compensation is $0.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intelligent Bio Solutions (INBS) Overvalued in 2026?

Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued. The current stock price of $2.25 is trading 13.8% below its estimated GF Value™ of $2.61. GuruFocus considers Intelligent Bio Solutions to be Modestly Undervalued.

Key valuation signals for INBS:

  • Stock Based Compensation: $0.11 Mil
  • GF Value™: $2.61 vs. price of $2.25 (13.8% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intelligent Bio Solutions Business Description

Address 135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
49GF Score

Get the complete analysis for INBS

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.25
Price
$2.61
GF Value